Table 2. Univariate analysis for risk of GAgP.

Variables	Statistics	Risk of GAgP	P-value
		OR (95% CI)
Age, years	27.21 ± 4.24	1.01 [0.96–1.06]	0.6875
Gender
Female	138 (38.98%)	Ref.
Male	216 (61.02%)	0.96 [0.62–1.49]	0.8587
BMI, Kg/m2	21.78 ± 3.37	1.08 [1.01–1.15]	0.0279*
BMI categories
<18.5	46 (13.22%)	Ref.
>=18.5, <24.9	244 (70.11%)	1.00 [0.53–1.89]	0.9964
>=24.9	58 (16.67%)	3.29 [1.37–7.91]	0.0079*
Alleles of rs2237051			0.0054*
A	482 (68.08%)	Ref.
G	226 (31.92%)	0.63 [0.46–0.87]
Genotype of rs2237051
GG	31 (8.76%)	Ref.
AG	164 (46.33%)	2.29 [1.04–5.04]	0.0388*
AA	159 (44.92%)	3.26 [1.47–7.22]	0.0036*
Genotype of rs2237051
AG/GG	195 (55.08%)	Ref.
AA	159 (44.92%)	1.62 [1.05–2.51]	0.0292*
Serum EGF, pg/ml	41.61 ± 11.14	1.17 [1.13–1.21]	<0.0001*

Notes:

^*P < 0.05, statistical significance.

Data were presented as OR (95%CI), outcome: Risk of GAgP.

Exposure: Age; BMI; BMI categories; Gender; genotype of rs2237051; serum EGF.